Immunocytochemical detection of epithelial cells in the bone marrow of primary breast cancer patients: A meta-analysis

Breast Cancer Research and Treatment

Volumn 87, Issue 3, 2004, Pages 215-224

  Weinschenker, Patrícia ^a   Soares, Heloisa Prado ^a   Clark, Otavio ^b   Giglio, Auro Del ^a  

^a Brazil   (Brazil)

^b Brazil   (Brazil)

Author keywords

breast neoplasms; immunocytochemistry and systematic review; neoplasm; residual

Indexed keywords

ESTROGEN RECEPTOR;

AXILLARY LYMPH NODE; BONE MARROW; BREAST CANCER; CANCER DIAGNOSIS; CANCER GRADING; CANCER SURVIVAL; CLINICAL TRIAL; CONFIDENCE INTERVAL; CORRELATION ANALYSIS; EPITHELIUM CELL; FOLLOW UP; HISTOLOGY; HUMAN; IMMUNOCYTOCHEMISTRY; MEDICAL LITERATURE; META ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVIEW; SYSTEMATIC REVIEW;

BONE MARROW; BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; EPITHELIAL CELLS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 8644285498     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-004-8691-1     Document Type: Review

References (29)

1. Early Breast Cancer Trialists' Collaborative Group: Polychemotherapy for early breast cancer: an overview of the randomised trials. Lancet 352: 930-942, 1998
2. Braun S, Pantel K, Muller P, Janni W, Hepp F, Kentenich CR, Gastroph S, Wischnik A, Dimpfl T, Kindermann G, Riethmuller G, Schlimok G: Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer. N Engl J Med 342: 525-533, 2000
3. Mansi JL, Easton D, Berger U, Gazet JC, Ford HT, Dearnaley D, Coombes RC: Bone marrow micrometastases in primary breast cancer: prognostic significance after 6 years' follow-up. Eur J Cancer 27: 1552-1555, 1991
4. Molino A, Pelosi G, Turazza M, Sperotto L, Bonetti A, Nortilli R, Fattovich G, Alaimo C, Piubello Q, Pavanel F, Micciolo R, Cetto GL: Bone marrow micrometastases in 109 breast cancer patients: correlations with clinical and pathological features and prognosis. Breast Cancer Res Treat 42: 23-30, 1997
5. Braun S, Kentenich C, Janni W, Hepp F, De Waal J, Willgeroth F, Sommer H, Pantel K: Lack of effect of adjuvant chemotherapy on the elimination of single dormant tumor cells in bone marrow of high-risk breast cancer patients. J Clin Oncol 18: 80-86, 2000
6. Funke I, Schraut W: Meta-analyses of studies on bone marrow micrometastases: an independent prognostic impact remains to be substantiated. J Clin Oncol 16: 557-566, 1998
7. Gerber B, Krause A, Muller H, Richter D, Reimer T, Makovitzky J, Herrnring C, Jeschke U, Kundt G, Friese K: Simultaneous immunohistochemical detection of tumor cells in lymph nodes and bone marrow aspirates in breast cancer and its correlation with other prognostic factors. J Clin Oncol 19: 960-971, 2001
8. Naume B, Borgen E, Kvalheim G, Karesen R, Qvist H, Sauer T, Kumar T, Nesland JM: Detection of isolated tumor cells in bone marrow in early-stage breast carcinoma patients: comparison with preoperative clinical parameters and primary tumor characteristics. Clin Cancer Res 7: 4122-4129, 2001
9. Mansi JL, Gogas H, Bliss JM, Gazet JC, Berger U, Coombes RC: Outcome of primary-breast-cancer patients with micrometastases: a long-term follow-up study. Lancet 354: 197-202, 1999
10. Molino A, Pelosi G, Micciolo R, Turazza M, Nortilli R, Pavanel F, Getto GL: Bone marrow micrometastases in breast cancer patients. Breast Cancer Res Treat 58: 123-130, 1999
11. Solomayer EF, Diel IJ, Salanti G, Hahn M, Gollan C, Schutz F, Bastert G: Time independence of the prognostic impact of tumor cell detection in the bone marrow of primary breast cancer patients. Clin Cancer Res 7: 4102-4108, 2001
12. Yusuf S, Peto R, Lewis J, Collins R, Sleight P: Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis 27: 335-371, 1985
13. Berger U, Bettelheim R, Mansi JL, Easton D, Coombes RC, Neville AM: The relationship between micrometastases in the bone marrow, histopathologic features of the primary tumor in breast cancer and prognosis. Am J Clin Pathol 90: 1-6, 1988
14. Cote RJ, Rosen PP, Lesser ML, Old LJ, Osborne MP: Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases. J Clin Oncol 9: 1749-1756, 1991
15. Dearnaley DP, Ormerod MG, Sloane JP: Micrometastases in breast cancer: long-term follow-up of the first patient cohort. Eur J Cancer 27: 236-239, 1991
16. Funke I, Fries S, Rolle M, Heiss MM, Untch M, Bohmert H, Schildberg FW, Jauch KW: Comparative analyses of bone marrow micrometastases in breast and gastric cancer. Int J Cancer 65: 755-761, 1996
17. Harbeck N, Untch M, Pache L, Eiermann W: Tumour cell detection in the bone marrow of breast cancer patients at primary therapy: results of a 3-year median follow-up. Br J Cancer 69: 566-571, 1994
18. Kirk SJ, Cooper GG, Hoper M, Watt PC, Roy AD, Odling-Smee W: The prognostic significance of marrow micrometastases in women with early breast cancer. Eur J Surg Oncol 16: 481-485, 1990
19. Pantel K, Schlimok G, Braun S, Kutter D, Lindemann F, Schaller G, Funke I, Izbicki JR, Riethmuller G: Differential expression of proliferation- associated molecules in individual micrometastatic carcinoma cells. J Natl Cancer Inst 85: 1419-1424, 1993
20. Schoenfeld A, Kruger KH, Gomm J, Sinnett HD, Gazet JC, Sacks N, Bender HG, Luqmani Y, Coombes RC: The detection of micrometastases in the peripheral blood and bone marrow of patients with breast cancer using immunohistochemistry and reverse transcriptase polymerase chain reaction for keratin 19. Eur J Cancer 33: 854-861, 1997
21. Egger M, Smith GD, Sterne JA: Uses and abuses of meta-analysis. Clin Med 1: 478-484, 2001
22. Altman DG: Systematic reviews of evaluations of prognostic variables. BMJ 323: 224-228, 2001
23. Deeks JJ: Systematic reviews in health care: systematic reviews of evaluations of diagnostic and screening tests. BMJ 323: 157-162, 2001
24. Manhani AR, Manhani R, Soares HP, Bendit I, Lopes F, Nicoletti AG, Fonseca FL, Novaes M, Zatta SM, Arias V, Giralt S, Del Giglio A: CK-19 expression by RT-PCR in the peripheral blood of breast cancer patients correlates with response to chemotherapy. Breast Cancer Res Treat 66: 249-254, 2001
25. Fonseca FLA, Soares HP, Manhani AR, Bendit I, Novaes M, Zatta SM, Arias V, Pinhal MAS, Weinschenker P, Del Giglio A: Peripheral blood C-Erbb-2 expression by reverse transcriptase- polymerase chain reaction in breast cancer patients receiving chemotherapy. Clin Breast Cancer 3: 201-205, 2002
26. Soares HP, Del Giglio A, Silva RS, Clark O, Kumar A, Djulbegovic B: Reverse transcriptase polymerase chain reaction for minimal residual disease detection in the peripheral blood of women with breast cancer: a meta-analysis. Proceedings of ASCO. Abstract 3531, 2003
27. Stathopoulou A, Vlachonikolis I, Mavroudis D, Perraki M, Kouroussis C, Apostolaki S, Malamos N, Kakolyris S, Kotsakis A, Xenidis N, Reppa D, Georgoulias V: Molecular detection of cytokeratin-19-positive cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic significance. J Clin Oncol 20: 3404-3412, 2002
28. Braun S, Cevatli BS, Assemi C, Janni W, Kentenich CR, Schindlbeck C, Rjosk D, Hepp F: Comparative analysis of micrometastasis to the bone marrow and lymph nodes of node-negative breast cancer patients receiving no adjuvant therapy. J Clin Oncol 19: 1468-1475, 2001
29. Borgen E, Beiske K, Trachsel S, Nesland JM, Kvalheim G, Herstad TK, Schlichting E, Qvist H, Naume B: Immunocytochemical detection of isolated epithelial cells in bone marrow: non-specific staining and contribution by plasma cells directly reactive to alkaline phosphatase. J Pathol 185: 427-434, 1998